2-Tridecanamine, N-methyl- | 1281816-05-4

• 分子结构分类: 有机化合物 - 有机氮化合物
• 英文名称: 2-Tridecanamine, N-methyl-
• 英文别名: N-methyltridecan-2-amine
• CAS: 1281816-05-4
• 化学式: C₁₄H₃₁N
• 分子量: 213.4
• InChiKey: DINFXLKUAXAKSA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.8
• 重原子数：
  15
• 可旋转键数：
  11
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  12
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] CYCLIC (POLY)GLYCEROL SULPHATES AND PREPARATION AND USE THEREOF<br/>[FR] (POLY)GLYCÉROL SULFATES CYCLIQUES ET LEUR PRÉPARATION ET UTILISATION
  申请人：RHODIA CHINA CO LTD

  公开号：WO2013067700A1

  公开（公告）日：2013-05-16

  The present invention relates to novel cyclic sulphates of (poly)glycerol, particularly to the novel compound of 4-(hydroxymethyl)-1,3,2-dioxathiolane-2,2-dioxide. The present invention also relates to the preparation process of the cyclic sulphate compounds, and to the use thereof as an intermediate to prepare green surfactants containing sulphate groups.

  本发明涉及新颖的(聚)甘油环状硫酸酯，特别是新化合物4-(羟甲基)-1,3,2-二氧硫杂环戊烷-2,2-二氧化物。本发明还涉及环状硫酸酯化合物的制备过程，以及将其用作中间体制备含有硫酸酯基团的绿色表面活性剂的用途。
• [EN] NOVEL METHOD TO MANUFACTURE SURFACE ACTIVE COMPOUNDS SUCH AS SULFATE BETAINE<br/>[FR] NOUVEAU PROCÉDÉ DE FABRICATION DE COMPOSÉS TENSIO-ACTIFS TELS QUE LE SULFATE BÉTAÏNE
  申请人：RHODIA OPERATIONS

  公开号：WO2013067915A1

  公开（公告）日：2013-05-16

  The present invention relates generally to novel methods of preparing compounds such as sulfate betaines by reacting an amine with a cyclic (poly)glycerol sulphate (CGS) compound and the compound such as sulfate betaine products obtained by using the same.

  本发明通常涉及通过将胺与环状（聚）甘油硫酸酯（CGS）化合物反应来制备硫酸盐甜菜碱等化合物的新方法，以及利用这些方法获得的硫酸盐甜菜碱等化合物产品。
• Indole Compound and Use Thereof
  申请人：Takeuchi Jun

  公开号：US20080188532A1

  公开（公告）日：2008-08-07

  The present invention relates to a compound represented by the formula (I), wherein all symbols are as defined in the description, a salt thereof, a solvate thereof, or a prodrug thereof, which has a leukotriene receptor antagonistic activity which is expected to be more effective than those of the leukotriene receptor antagonists currently used in clinical trials. Therefore, it is useful as an agent for the prevention and/or treatment of a leukotriene-mediated disease such as a respiratory diseases such as bronchial asthma, chronic obstructive pulmonary disease, pulmonary emphysema, chronic bronchitis, pneumonia (e.g. interstitial pneumonia etc.), severe acute respiratory syndrome (SARS), acute respiratory distress syndrome (ARDS), allergic rhinitis, sinusitis (e.g. acute sinusitis, chronic sinusitis, etc.), or the like, or as an expectorant or an antiitussive.

  本发明涉及一种化合物，其表示为公式（I），其中所有符号如描述中所定义，其盐，溶剂化物或前药，具有期望比目前在临床试验中使用的白三烯受体拮抗剂更有效的白三烯受体拮抗作用。因此，它可用作预防和/或治疗白三烯介导的疾病，例如呼吸系统疾病，如支气管哮喘，慢性阻塞性肺疾病，肺气肿，慢性支气管炎，肺炎（例如间质性肺炎等），严重急性呼吸综合征（SARS），急性呼吸窘迫综合征（ARDS），过敏性鼻炎，鼻窦炎（例如急性鼻窦炎，慢性鼻窦炎等），或作为祛痰剂或止咳剂。
• LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT
  申请人：JNC Corporation

  公开号：EP3275973A1

  公开（公告）日：2018-01-31

  Subject The subject is to provide a liquid crystal composition that includes a polymerizable compound (or polymer) and a polar compound, where the homeotropic alignment of liquid crystal molecules can be achieved by the action of these compounds, and a liquid crystal display device including this composition. This composition satisfies at least one of characteristics such as a high maximum temperature, a low minimum temperature, a small viscosity, a suitable optical anisotropy, a large positive dielectric anisotropy, a large specific resistance, a high stability to ultraviolet light or heat or a large elastic constant, or is suitably balanced regarding at least two of the characteristics. The means concerns a nematic liquid crystal composition that has positive dielectric anisotropy and that includes a polymerizable compound as an first additive and a polar compound as a second additive, and the composition may include a specific liquid crystal compound having a large positive dielectric anisotropy and a specific liquid crystal compound having a high maximum temperature or a small viscosity, and concerns a liquid crystal display device including the composition.

  主题 本课题旨在提供一种液晶组合物，其中包括一种可聚合化合物（或聚合物）和一种极性化合物，通过这些化合物的作用可实现液晶分子的各向同性排列，并提供一种包括这种组合物的液晶显示装置。这种组合物至少满足以下一种特性，如最高温度高、最低温度低、粘度小、光学各向异性合适、正介电各向异性大、比电阻大、对紫外线或热的稳定性高或弹性常数大，或至少在其中两种特性方面适当平衡。 该手段涉及一种具有正介电常数的向列液晶组合物，该组合物包括作为第一添加剂的可聚合化合物和作为第二添加剂的极性化合物，该组合物可包括具有较大正介电常数的特定液晶化合物和具有较高最高温度或较小粘度的特定液晶化合物，还涉及一种包括该组合物的液晶显示设备。
• Assay method for the detection of viable microbial cells in a sample
  申请人：3M INNOVATIVE PROPERTIES COMPANY

  公开号：US10196671B2

  公开（公告）日：2019-02-05

  The present invention discloses an assay method for the detection of viable microbial cells in a sample, the assay method comprising the steps of: i) adding an ATP degrading enzyme to a sample suspected of containing viable microbial cells to substantially degrade any extracellular ATP in the sample; ii) adding a phosphate containing compound to the sample to substantially halt action of the ATP degrading enzyme; and iii) subjecting the sample to a detection assay to establish the level of undegraded ATP in the sample to provide an indication of the level of viable microbial cells in the sample.

  本发明公开了一种检测样品中可存活微生物细胞的检测方法，该检测方法包括以下步骤：i) 向怀疑含有可存活微生物细胞的样品中加入 ATP 降解酶，以大量降解样品中的细胞外 ATP； ii) 向样品中加入含磷酸盐的化合物，以大量阻止 ATP 降解酶的作用；以及 iii) 对样品进行检测试验，以确定样品中未降解 ATP 的水平，从而提供样品中可存活微生物细胞水平的指示。